Live Quote · OTCACBMHealthcare · Biotechnology

Acro Biomedical Co., Ltd.

$0.03▲ 0.00%(+$0.00)

TickerSpark Score

42/100

▌ Weak

60

Valuation

40

Profitability

15

Growth

36

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACBM research report →

52-Week Range25% of range

Low

$0.00

Current

$0.03

High

$0.10

Company Overviewacrobiomedicalco.com

About the company

Acro Biomedical Co. , Ltd. focuses on the development and commercialization of dietary supplements.

CEO: Yu-Ting Su
IPO: 2021
Employees: 1
HQ: Fishers, IN, US

Price Chart

+3614.29% · this period

Valuation

Market Cap: $1.56M
P/E: -11.60
P/S: 0.00
P/B: -3.65
EV/EBITDA: -9.41
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 34.42%
ROIC: 48.07%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-101,146 · -139.13%
EPS: $-0.00 · -142.86%
Op Income: $-154,024
FCF YoY: -435.00%

Performance & Tape

52W High: $0.10
52W Low: $0.00
50D MA: $0.03
200D MA: $0.02
Beta: -2.53
Avg Volume: 6

Get TickerSpark's AI analysis on ACBM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · ACBM